| Name | Title | Contact Details |
|---|
Medrecon is a Garwood, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
RyMed Technologies is a Mobile, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Wound Healing Solutions provides high quality, accessible and research driven wound management services to the patient`s bedside. Serving the long-term care and assisted living communities of New Jersey, Pennsylvania, Delaware, Maryland, Virginia and New York- our wound certified nurse practitioners provide socially responsible wound management.
Deposition Sciences is a Santa Rosa, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AgaMatrix is revolutionizing health care. We`ve sold over a million devices, two billion sensors, and we are the first FDA cleared medical device/app that works with iOS. AgaMatrix is an inventor and leader in consumer healthcare technology. With fewer than 150 people, almost 50% in R&D, we develop glucose monitoring and management systems for diabetes. Diabetes related care accounts for 20% of all healthcare spending in the US. Our innovative multidisciplinary technology vision includes iPhone, Android, and web applications supported by a cloud-based, Java back end for data management and exchange between patients and their doctors. Our UI/UX won the prestigious red dot design award. Our proprietary tech platform, protected by 126 granted/pending patents, uses DSP algorithms to double accuracy while reducing cost by 50%. AgaMatrix not only developed the first FDA cleared medical device that connects to an iPhone, but has over a dozen other FDA cleared products, and has sold over 2.5M meters and 3B biosensors. Our products are available in 20,000 retail locations and a worldwide in partnership with Sanofi, the world's largest pharmaceutical company. We`ve been featured by the New York Times and Fast Company, and we work with the world`s largest retailers (Walmart, Kroger, Target) and pharmaceutical companies (Sanofi, Perrigo) to change the way diabetes is treated.